Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (1086)
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
1,051
Price
$26.16
Total Value
$27.49K
Shares Held After
19,059
% of Holdings
5.2%
ANAPTYSBIO, INC (ANAB)
RENTON HOLLINGS — Director
Shares
5,000
Price
$49.87
Total Value
$249.37K
Shares Held After
10,995
% of Holdings
31.3%
Oric Pharmaceuticals, Inc. (ORIC)
Heyman Richard A. — Director
Shares
3,200
Price
$12.91
Total Value
$41.33K
Shares Held After
203,472
% of Holdings
1.5%
Oric Pharmaceuticals, Inc. (ORIC)
Heyman Richard A. — Director
Shares
3,500
Price
$12.91
Total Value
$45.20K
Shares Held After
38,300
% of Holdings
8.4%
Verastem, Inc. (VSTM)
Paterson Dan — Director
Shares
44,121
Price
$8.00
Total Value
$352.97K
Shares Held After
652,712
% of Holdings
6.3%
ORAMED PHARMACEUTICALS INC. (ORMP)
Gabay Avraham — Chief Financial Officer
Shares
20,000
Price
$4.51
Total Value
$90.20K
Shares Held After
861,076
% of Holdings
2.3%
ORAMED PHARMACEUTICALS INC. (ORMP)
Hexter Joshua — COO&CBO
Shares
30,000
Price
$4.51
Total Value
$135.33K
Shares Held After
1,328,130
% of Holdings
2.2%
Verastem, Inc. (VSTM)
Calkins Daniel — Chief Financial Officer
Shares
2,566
Price
$8.00
Total Value
$20.53K
Shares Held After
123,781
% of Holdings
2.0%
HALOZYME THERAPEUTICS, INC. (HALO)
Posard Matthew L. — Director
Shares
100
Price
$110.04
Total Value
$11.00K
Shares Held After
53,609
% of Holdings
0.2%
HALOZYME THERAPEUTICS, INC. (HALO)
Posard Matthew L. — Director
Shares
1,100
Price
$109.57
Total Value
$120.53K
Shares Held After
53,709
% of Holdings
2.0%
HALOZYME THERAPEUTICS, INC. (HALO)
Posard Matthew L. — Director
Shares
3,300
Price
$108.45
Total Value
$357.90K
Shares Held After
54,809
% of Holdings
5.7%
HALOZYME THERAPEUTICS, INC. (HALO)
Posard Matthew L. — Director
Shares
730
Price
$107.17
Total Value
$78.23K
Shares Held After
58,109
% of Holdings
1.2%
Xeris Biopharma Holdings, Inc. (XERS)
Hecht Beth — Chief Legal Officer and Corporate Secretary
Shares
16,666
Price
$9.41
Total Value
$156.79K
Shares Held After
1,111,130
% of Holdings
1.5%
Xeris Biopharma Holdings, Inc. (XERS)
Pieper Steven — Chief Financial Officer
Shares
5,000
Price
$9.41
Total Value
$47.04K
Shares Held After
1,351,053
% of Holdings
0.4%
Xeris Biopharma Holdings, Inc. (XERS)
McCulloch Kevin — President and Chief Operating Officer
Shares
15,000
Price
$9.41
Total Value
$141.12K
Shares Held After
1,599,208
% of Holdings
0.9%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
17,000
Price
$97.46
Total Value
$1.66M
Shares Held After
197,209
% of Holdings
7.9%
Compass Therapeutics, Inc. (CMPX)
Lerner Neil — Chief Accounting Officer
Shares
20,000
Price
$0.92
Total Value
$18.40K
Shares Held After
420,000
% of Holdings
4.8%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
262
Price
$116.12
Total Value
$30.42K
Shares Held After
666,568
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
8,230
Price
$115.40
Total Value
$949.74K
Shares Held After
666,830
% of Holdings
1.2%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
7,601
Price
$114.43
Total Value
$869.78K
Shares Held After
675,060
% of Holdings
1.1%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
4,876
Price
$113.24
Total Value
$552.16K
Shares Held After
682,661
% of Holdings
0.7%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
5,506
Price
$112.42
Total Value
$618.98K
Shares Held After
687,537
% of Holdings
0.8%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
3,525
Price
$111.44
Total Value
$392.83K
Shares Held After
693,043
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
160
Price
$573.15
Total Value
$91.70K
Shares Held After
45,172
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
823
Price
$572.25
Total Value
$470.96K
Shares Held After
45,332
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
838
Price
$570.90
Total Value
$478.41K
Shares Held After
46,155
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
739
Price
$569.15
Total Value
$420.60K
Shares Held After
46,993
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
720
Price
$567.76
Total Value
$408.79K
Shares Held After
47,732
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
400
Price
$566.41
Total Value
$226.56K
Shares Held After
48,452
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,480
Price
$563.09
Total Value
$833.37K
Shares Held After
48,852
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
780
Price
$561.87
Total Value
$438.26K
Shares Held After
50,332
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,480
Price
$560.19
Total Value
$829.08K
Shares Held After
51,112
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
880
Price
$558.30
Total Value
$491.31K
Shares Held After
52,592
% of Holdings
1.6%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
17,500
Price
$89.89
Total Value
$1.57M
Shares Held After
79,762
% of Holdings
18.0%
Shares
556,000
Price
$4.96
Total Value
$2.76M
Shares Held After
3,236,171
% of Holdings
14.7%
Protagonist Therapeutics, Inc (PTGX)
Ali Asif — Chief Financial Officer
Shares
46,034
Price
$141.78
Total Value
$6.53M
Shares Held After
59,003
% of Holdings
43.8%
Protagonist Therapeutics, Inc (PTGX)
Ali Asif — Chief Financial Officer
Shares
12,595
Price
$141.77
Total Value
$1.79M
Shares Held After
105,037
% of Holdings
10.7%
NewAmsterdam Pharma Co N.V. (NAMS)
Kastelein Johannes Jacob Pieter — Director
Shares
50,246
Price
$25.03
Total Value
$1.26M
Shares Held After
69,302
% of Holdings
42.0%
Mineralys Therapeutics, Inc. (MLYS)
Congleton Jon — Director
Shares
75,000
Price
$25.46
Total Value
$1.91M
Shares Held After
528,621
% of Holdings
12.4%
Roivant Sciences Ltd. (ROIV)
Venker Eric — President&Immunovant CEO
Shares
200,000
Price
$36.62
Total Value
$7.32M
Shares Held After
1,599,154
% of Holdings
11.1%
Tectonic Therapeutic, Inc. (TECX)
McNamara Peter — Chief Scientific Officer
Shares
536
Price
$23.04
Total Value
$12.35K
Shares Held After
54,305
% of Holdings
1.0%
PTC THERAPEUTICS, INC. (PTCT)
STEELE GLENN JR MD PHD — Director
Shares
12,000
Price
$65.16
Total Value
$781.92K
Shares Held After
22,500
% of Holdings
34.8%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
1,115
Price
$375.00
Total Value
$418.12K
Shares Held After
0
% of Holdings
100.0%
Alto Neuroscience, Inc. (ANRO)
Smith Nicholas Conrad — PRESIDENT AND CFO
Shares
886
Price
$26.87
Total Value
$23.81K
Shares Held After
24,060
% of Holdings
3.6%
Alto Neuroscience, Inc. (ANRO)
Smith Nicholas Conrad — PRESIDENT AND CFO
Shares
23,170
Price
$25.78
Total Value
$597.29K
Shares Held After
24,946
% of Holdings
48.2%
Lipocine Inc. (LPCN)
Higuchi John W. — Director
Shares
15,970
Price
$2.23
Total Value
$35.61K
Shares Held After
241,365
% of Holdings
6.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$546.23
Total Value
$196.64K
Shares Held After
326,363
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
920
Price
$545.13
Total Value
$501.52K
Shares Held After
326,723
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
840
Price
$544.05
Total Value
$457.00K
Shares Held After
327,643
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$543.25
Total Value
$325.95K
Shares Held After
328,483
% of Holdings
0.2%
Showing 51–100 of 1086 transactions (page 2 of 22)